Page last updated: 2024-10-25

debrisoquin and Deficiency of Glucose-6-Phosphate Dehydrogenase

debrisoquin has been researched along with Deficiency of Glucose-6-Phosphate Dehydrogenase in 2 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Omenn, GS1
Evans, DA1

Reviews

2 reviews available for debrisoquin and Deficiency of Glucose-6-Phosphate Dehydrogenase

ArticleYear
Ethnic differences in reactions to drugs and xenobiotics. Susceptibility to occupational and environmental exposures to chemicals.
    Progress in clinical and biological research, 1986, Volume: 214

    Topics: Acetylation; alpha 1-Antitrypsin; Anemia, Hemolytic; Aryl Hydrocarbon Hydroxylases; Asian People; Ba

1986
Ethnic differences in reactions to drugs and xenobiotics. Therapy.
    Progress in clinical and biological research, 1986, Volume: 214

    Topics: Acetylation; Debrisoquin; Drug Interactions; Drug Therapy; Drug-Related Side Effects and Adverse Rea

1986